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INTRODUCTION
Death anxiety refers to the experience of fear, panic, dread and other distress associated with the awareness of one's mortality. [2] Although all humans face the inevitability of death, the extent to which it is a salient and conscious threat may differ greatly across contexts and the lifespan. [3] Death anxiety may be expected to be common in individuals with advanced cancer, although to date, there has been relatively little empirical research on this outcome in this population. [4] Prior research on death anxiety has focused on those for whom mortality is not imminent, [5] owing to the perceived difficulties of studying individuals with advanced disease and to the protectiveness of health care professionals, who may regard research to be intrusive to these patients. [6] The anticipation of death can be deeply disturbing to patients with advanced cancer, who may struggle with balancing the possibilities of life with the finality of dying. Maintaining this "double awareness" [7] challenges one's inner strength and beliefs and social connectedness, and individuals may vacillate between periods of optimism and overwhelming death anxiety. [8] Death anxiety has been associated with depression, anxiety and physical distress in cancer, [2, 9] and has been shown to compromise quality of life in those with terminal illness. [10] Preliminary research has shown that death anxiety is elevated in advanced cancer [11] and research with a measure of death anxiety specific to ill populations suggests it may be more common than depression. [2] This measure, the Death and Dying Distress Scale (DADDS) assesses distress associated with the loss of time and opportunity, the potential impact of one's death on others, and the process of dying. [2] In the present study, we investigate death anxiety and its determinants in patients with advanced cancer because of the potential that such knowledge may contribute to therapeutic interventions that prevent or alleviate such distress. [12] We have relied on two explanatory frameworks, Terror Management Theory (TMT) [13] and a life stage perspective [14] , to generate hypotheses concerning factors associated with death anxiety.
Terror Management Theory addresses the psychological means by which humans may shield themselves from the terror invoked by thoughts of mortality and the transience of life. [13] The theory posits that self-esteem and the sense that one's life has meaning and value are the individual's primary defenses against death anxiety. This is consistent with the finding that meaning and purpose in life protect against death anxiety in advanced cancer. [11] TMT hypothesizes that humans derive meaning through a set of cultural worldviews and beliefs, and that self-esteem is rooted in feelings of comfort and contentment that arise from living in accordance with these personal and cultural principles. The achievements of a successful life, whether in work or art or embodied in relationships with family and offspring, may serve to promote a sense of symbolic immortality. [15] Religious worldviews may also decrease death anxiety with their promise of an afterlife. [16] In an expansion of TMT, Hart et al. [17] proposed that an additional protective mechanism against death anxiety is attachment security, or the ability to find comfort in social relationships. The motivation to find protection and support from others when under stress has been considered evolutionarily adaptive and has been associated with numerous positive outcomes throughout life. [18] Death anxiety may also vary by life stage. Cancer patients with young children may have greater worries about the impact of their death on their families than those without. [14] Such concerns may center around the loss of these relationships, being deprived of the opportunity to nurture children into maturity, [19] and awareness of the potential adverse effect of losing a parent or caretaker on the development of children. [20] We expected age to be negatively associated with death anxiety, as it is with other symptoms of distress, [21] although the age-related findings in the literature regarding death anxiety have been inconsistent. [22] [23] [24] [25] Death and dying may be more frightening and tragic for younger patients because fatal illness is a much greater deviation from their expected life course and because they may have a less welldeveloped capacity than older individuals to manage a traumatic event of this kind. [15, 21, 26] Based on this previous research, we hypothesized that self-esteem, the sense of meaning in life, faith, and age would be negatively associated with death anxiety in patients with advanced cancer. We expected death anxiety to be positively associated with having young children, and with attachment anxiety (i.e. fear of abandonment) and avoidance (i.e. defensive independence and discomfort with closeness), the two dimensions of attachment security. [27] Finally, we expected greater symptom burden from disease to be positively associated with death anxiety, because physical suffering may increase the salience of mortality. Although our hypotheses are presented as individual relationships, our overall aim was to offer a simultaneous test of them to identify the most proximal predictors of death anxiety adjusted for confounding effects. These factors may be the most important to consider when intervening with patients to alleviate death anxiety.
METHODS

Participants and Procedure
This study received ethics approval from the University Health Network Research Ethics Board. Participants were outpatients with advanced cancer from the Princess Margaret Cancer Centre, a comprehensive cancer treatment facility in Toronto, Canada, part of the University Health Network. They were recruited into a phase 2 pilot study of a psychological intervention for those with advanced cancer, called Managing Cancer and Living Meaningfully (CALM). CALM addresses four specific domains: (1) symptom management and communication with healthcare providers, (2) changes in self and relations with close others, (3) spirituality or sense of meaning and purpose, and (4) thinking of the future, hope and mortality. [12] As part of recruitment, the intervention and the study purpose to test its effectiveness to alleviate emotional distress and to promote wellbeing were described to patients. After providing written informed consent, participants gave basic medical and demographic information and were randomized into intervention or usual care conditions. They completed self-report questionnaires at baseline, 3 months and 6 months. Participants randomized to usual care were offered therapy at the end of the study. The present paper is an analysis of the baseline data from this pilot study. Outcome data is not reported here, as death anxiety was expected to be affected by the intervention.
Eligible participants were 18 years of age or older, sufficiently fluent in English to provide informed consent, and had a confirmed diagnosis in the medical chart of Stage IIIB or IV lung cancer, or Stage IV endocrine, breast, gastrointestinal, genitourinary or gynecologic cancer, except for patients with pancreatic or ovarian cancer who were eligible at any stage due to the aggressiveness of disease. Individuals were excluded if they showed cognitive impairment, as measured by the Short Orientation-Memory-Concentration Test [28] administered by a research assistant. Individuals were also excluded if they were receiving in-hospital psychosocial assistance from a psychiatrist or psychologist at the time of recruitment to limit contamination of the usual care group with alternate psychological interventions.
Recruitment occurred from June, 2011 to February, 2012. Two hundred and fifty two patients were identified as having a diagnosis of advanced cancer through the Electronic Patient Record (i.e. computerized medical charts), introductory letters were mailed to those who met medical eligibility, and they were then approached by a research staff member for study recruitment while attending outpatient oncology clinics at the Princess Margaret Cancer Centre. Of the 252 individuals approached, 77 (31%) consented to participate and 60 (23%) entered the study and were randomized. The loss of 17 consenters was due to the following reasons: 7 were ineligible upon further review, 4 reported loss of interest, 3 were too ill, 2 were lost to contact, and 1 chose not to participate because of involvement in another trial. No information was collected concerning those who refused to consent to this study.
Measures
Medical and demographic data were obtained from participants at recruitment and also extracted from medical charts. Physical burden of disease was assessed using a brief version of the Memorial Symptom Assessment Scale, [29] which measures the presence and severity of 28 common physical symptoms of cancer in the past week. This instrument generated a physical symptom count variable indicative of overall disease burden and allowed for the identification of individual symptoms that were of at least moderate severity.
Death anxiety was measured using the 15-item Death and Dying Distress Scale, a new measure developed for use with individuals facing life-threatening disease and validated in patients with advanced cancer. [2] Preliminary psychometric analyses revealed excellent internal reliability, Cronbach's alpha = 0.93, and good construct validity as demonstrated by significant correlations with depression and emotional and physical wellbeing. [2] In the present study, the instrument was found to be reliable, Cronbach's alpha = 0.95. DADDS scores may range from 0-75, with higher scores indicating greater death-related distress. A cut-off-score of 45 may be used to identify individuals with at least moderate levels of death anxiety, as this value is associated with having rated '3' (i.e. I experienced moderate distress) across the 15 items of the scale.
Self-esteem was measured using the 10-item Rosenberg Self-esteem Scale, a widely used and well-validated measure of self-concept. [30] Scores may range from 10-40, with higher scores indicating greater self-esteem.
The sense of meaning in life and spiritual faith were measured using the 12-item Functional Assessment of Chronic Illness Therapy -Spiritual Well-being Scale. [31] This instrument has subscales assessing the degree to which individuals feel they have a sense of meaning, purpose and peace, and the degree to which they are able to derive comfort and strength from their faith or spiritual beliefs. Scores on the meaning subscale may range from 0-32 and faith scores may range from 0-16. Higher values indicate greater meaning or faith, respectively.
Attachment security was assessed with the 16-item Modified Experiences in Close Relationships scale, an instrument tailored for use with medical populations. [27] It measures two dimensions of attachment security, specifically, attachment anxiety and attachment avoidance. Each subscale score may range from 8-56, with higher scores indicating greater attachment anxiety or avoidance.
Statistical Analysis
Descriptive statistics were calculated for sample characteristics and variables. Given the theoretical importance of self-esteem to the present study, we used a t-test to determine whether the mean self-esteem observed in the sample may differ from that observed in a survey of over 700 patients with advanced cancer at Princess Margaret Cancer Centre, which also used the Rosenberg Self-Esteem Scale. [32] The main predictors or explanatory factors of interest in this study were age, symptom count, and presence of children in the family under 18 years old, self-esteem, attachment anxiety, attachment avoidance, and meaning and faith. In anticipation of conducting regression analyses on death anxiety, we examined the normality of this outcome and the seven continuous predictor variables using visual methods and the Cramér-von Mises test. The significance criterion used per test was set at p = 0.006, after applying a Bonferroni correction to control the overall Type 1 error rate at p = 0.05. When a variable was found to be non-normal, we used an algorithm to search for an optimal Box-Cox power transformation that might normalize the variable. [33] For descriptive purposes, simple zero-order correlations were calculated between death anxiety and the main predictors of interest. The primary analysis was a stepwise regression with backward elimination. We chose backward elimination because the small number of predictors and our equal interest in them recommended that the starting condition include all factors. The criterion for retention of a predictor in the model was set at p = 0.05.
Lastly, as an exploratory analysis, we examined the relationship between specific physical symptoms and death anxiety. We conducted a stepwise regression with forward entry in which the criterion for entry of a predictor into the model was p = 0.05. The outcome was death anxiety and all 28 physical symptoms were made available for possible entry into the model. The large number of symptoms and the lack of prior hypotheses recommended that the model be built from scratch using a forward selection method. Table 1 provides descriptive statistics on the sample of 60 participants. The sample was mostly female (70%), white (92%), married (67%) and educated above the high school level (83%). The most common cancer site was gastrointestinal (47%) and the mean time since cancer diagnosis was 2.5 years. Table 2 provides further information about symptom burden in the sample. The most common symptoms of at least moderate severity were lack of energy (68%), pain (47%), difficulty sleeping (47%) and drowsiness (45%). Table 3 gives detailed item-level statistics on the DADDS to summarize the pattern and frequency of death-related concerns. The mean selfesteem score in the sample was 33, SD = 5, which was not significantly different from the mean self-esteem score of 34, SD = 4.8, found in a large sample survey of patients with advanced cancer [26] , t(772) = 1.54, p = 0.12.
RESULTS
Concerning the tests of normality, the only variable found to be significantly non-normal was faith, W 2 = 0.24, p < 0.005. A graph of the variable revealed its distribution to lack kurtosis. The optimal Box-Cox transformation for normalizing this variable was identified by algorithm. [33] However, even this transformation failed to normalize the factor and so we chose to use the variable in its original untransformed state.
There were significant zero-order relationships between death anxiety and self-esteem, symptom count, attachment anxiety, meaning and faith (see Table 4 ). Nonetheless, the regression of death anxiety on the explanatory factors found it to be negatively predicted by self-esteem and positively predicted by number of physical symptoms, having young children, and marginally, by age (see Table 5 ). This model accounted for 47% of the variance in death anxiety.
The regression of death anxiety on specific physical symptoms revealed it be to positively predicted by changes in physical appearance (i.e. 'I don't look like myself'), b(se) = 18. 
DISCUSSION
In this study of patients with metastatic cancer participating in a psychological treatment study, we found death anxiety to be relatively common, with 32% of the sample reporting death anxiety of at least moderate severity based on a cut-off score of 45 on the DADDS. Factors associated with death anxiety in the regression analyses were a greater number of physical symptoms, lower self-esteem, having dependent children, and increasing age. Contrary to our hypotheses, we did not find a relationship between attachment security and death anxiety or an inverse relationship between age and death anxiety.
An examination of the median scores on each item of the DADDS revealed that at least half the sample was moderately to extremely distressed on 6 of 15 items. The item rated as most distressing on the DADDS asked about the impact of one's death on others, suggesting that death anxiety is importantly a relational concern. The DADDS items rated as least distressing concerned fear of dying alone or of dying suddenly, consistent with previous findings in an advanced cancer sample. [2] The low level of distress about dying alone may indicate the presence of meaningful family support and medical care for most individuals in this sample. A swift death in advanced cancer may not be feared this population in that it avoids prolonged suffering. Indeed, regression analyses found that greater death anxiety was related to overall symptom burden, of which fatigue, pain, drowsiness and difficulty sleeping were most common. Physical and psychological distress has been shown to be closely tied in diverse populations, [34] [35] [36] but physical suffering and changes in physical appearance in the context of terminal disease may also increase the salience of mortality and its related fears. In this study, the physical symptoms most strongly related to death anxiety were changes in physical appearance and pain. These two symptoms may be the most difficult to mask and the most suggestive of disease progression, thereby heightening death-related distress.
Self-esteem in the present study was a protective factor against death anxiety, consistent with Terror Management Theory. [13, 37] The novelty of this finding lies in its demonstration in those for whom death is imminent. By contrast, the majority of TMT studies have examined the relationship between self-esteem and death anxiety in healthy individuals, showing that selfesteem and death anxiety are inversely related and that self-esteem may buffer the effects of mortality salience. [38] [39] [40] It remains to be determined whether therapeutic interventions aimed at supporting self-worth can diminish death anxiety in the context of terminal illness. However, it is evident that physical deterioration from disease may undermine basic sources of self-esteem, including bodily appearance and functioning, social engagement, the capacity to work and play, and the capacity for self-care before the end of life. [41] [42] [43] A strong premorbid sense of self may help to preserve self-esteem in the face of these losses and thereby protect from death anxiety. The preservation of self-worth and alleviation of death anxiety may require a process of life review [43, 44] and sufficient time and support for self-reflection to allow individuals the opportunity to mourn their losses and to accept the inevitability of death. [12] We found that patients with young children had greater death anxiety than those without. This anxiety may be rooted in realistic concerns for the well-being of their children who are at a vulnerable stage of development. [45] The alleviation of death anxiety in patients with young families may therefore require attention to these concerns and to planning for the future needs of their children. After controlling for the presence of dependent children, there remained a positive association between death anxiety and age. This marginally significant effect was contrary to expectation but may be explained by age-related differences in mortality salience. The ages observed in this study ranged from 31 to 85 years, with the middle 50% of the distribution falling between 50 and 65 years. Increasing age may be associated with more frequent contemplation of death, owing to more experience with frailty and physical decline [46] and with the deaths of loved ones. [24] This greater mortality salience may be associated with a greater capacity and willingness to reflect on death, and to acknowledge its attendant fears. Conversely, younger patients may have less prior experience with illness or death and may be more reluctant or have less capacity to reflect on or to acknowledge mortality-related concerns. [21, 25] Future work will need to clarify the nature of age-related changes in death anxiety.
Study limitations which circumscribe its generalisability include its small sample size, underrepresentation of individuals less than 30 years of age and non-White participants, and recruitment of individuals into a psychological treatment study. It is unclear to what extent the lack of statistical power has contributed to the non-significance of certain predictors, such as attachment security. The cross-sectional and correlational nature of the data does not allow for causal conclusions to be drawn.
The low participation rate in this study exemplifies the challenges of conducting research in this population, for whom time is short and physical burden of disease is high. The sampling in the present study may have also been affected by the overall design which involved a psychological intervention. Patients who were struggling with death anxiety but reluctant to discuss these concerns with a therapist may have declined to participate in the treatment study, leading to an underestimation of death anxiety. On the other hand, it is equally possible that patients with greater distress and dying were more motivated to participate in the therapeutic intervention.
In conclusion, the findings of this study confirm that death anxiety is an important outcome to address in those with life-limiting cancer. We found life stage, particularly having dependent children, and individual factors, such as lower self-esteem, and physical suffering to increase the vulnerability to death anxiety. Overall, the alleviation of death-related distress may require a multidimensional approach which considers individual concerns, family support, and management of physical symptoms. Future research should seek to develop a more comprehensive understanding of the determinants of death anxiety, which may include the loss of control and feelings of powerlessness. [47] 
WHAT IS ALREADY KNOWN ON THIS TOPIC
It may be expected that death anxiety is prevalent in patients with advanced cancer, although there has been little data on the presence of and factors associated with death anxiety in this population.
WHAT THIS STUDY ADDS
We have demonstrated that death anxiety is relatively common in advanced cancer, and is positively associated with symptom burden, the presence of children under 18, and age, and negatively associated with self-esteem. These findings support a multidimensional approach to alleviating death anxiety that addresses individual concerns, family support, and management of physical symptoms. 
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